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Background: The reduction ascending aortoplasty in patients with an aortic ectasia/dilatation is a common
procedure during concomitant cardiac operations. Aim of the follow up study was the evaluation of possible
re-dilatation and complications.
Methods: From 1998 to 2010 124 patients (69% male; mean age 66.6 ± 12 ys) with ectasia of the ascending
aortic who had no further indication for an aortic replacement, were included. The mean preoperative diameter
of the ascending aorta was 4.2 ± 0.6 cm. The patients risk profile was moderate (mean EF 51% ± 11%, Euroscore
4.2 ± 2.1). To treat the dilatation of the ascending aorta, a longitudinal incision was performed and a strip of the
aortic wall was resected. A reduction aortoplasty was carried out with a double-layered suture line using a 4/0
Prolene mattress suture with an additional 4/0 Prolene running suture. A follow up (rate 95%) was performed
by echocardiography- and clinical examination.
Results: All patients underwent reduction aortoplasty associated with a primary cardiac surgical procedure
(AVR 63%, CABG 13%, other or combination 24%). The intrahospital mortality rate was 4%. Four aortic bleeding
complications occurred. After a mean postoperative period of 57 ± 39 months, the ascending aortic diameter
(3.6 ± 0.6 cm) was still significantly (P < 0.01) reduced. No postoperative aortic-related complications including
aortic rupture, dissection and reoperation were observed. In 4 patients, the ascending aorta had re-dilated to
the preoperative diameter.
Conclusion: Reduction ascending aortoplasty without external wrapping is a safe procedure with acceptable
midterm results in patients with asymptomatic dilatations and concomitant cardiac surgical procedures.
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A number of surgical techniques and materials are cur-
rently available for the treatment of aneurysms of the as-
cending aorta. Choosing the right technique requires
careful review of the various factors, such as morphology
of the aneurysm, dilatation of the aortic root, an additional
aortic defect and the risks associated with surgery [1,2].
If the dilatation affects only the ascending aorta, aortic
replacement is the most common procedure and may
potentially be combined with aortic valve replacement.
This procedure provides good results [2] but is still asso-
ciated with significant risks. Perioperative mortality and
morbidities can vary up to 10% [1-4].* Correspondence: cardiac.surgeon@dr-kiessling.com
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unless otherwise stated.Reduction ascending aortoplasty (RAA) constitutes an
alternative to replacing the ascending aorta in patients
with ascending aneurysm without involvement of the
aortic root [5]. This is a viable procedure which has
demonstrated a number of advantages (less invasive as
compared to replacement with a Dacron graft, shorter
aortic clamping time, lower risk of bleeding) [6-8]. In
addition, lower mortalities and morbidities were re-
ported in patients with RAA [9]. The RAA remains,
however, a controversial surgical option due to the po-
tential risk of re-dilatation. This is why the procedure is
generally limited to patients with a high perioperative
risk. [2]. Reduction ascending aortoplasty is often used
in older patients with non-dissecting aortic aneurysm, in
particular as an added procedure with concomitant car-
diosurgical intervention [8,9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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literature. Oftentimes synthetic wrapping is used in
addition for external support. Our follow-up study,
however, included only patients who underwent sur-
gery with the Robicsek et al technique [7,10] (without
external support). This follow-up study was designed
to assess medium long-term results of non-Dacron
supported RAA procedures and determine the poten-
tial predictors for re-dilatation.
Methods
From January 1998 until 2010, 124 patients underwent
reduction ascending aortoplasty associated with dilata-
tion and ectasia of the ascending aorta. From 2011 to
2012 the patients were asked to return for a follow-up
echocardiography at the Frankfurt am Main University
Hospital. The study had been approved by our institu-
tional ethics committee and the investigator obtained
written consent from each patient (decree 184/12 Ethic
committee Goethe University, Frankfurt, Germany). The
aortoplasty was performed when replacement of the as-
cending aorta was not indicated for patients (>5 cm) or
existing pre-operative concomitant diseases would have
considerably increased the risk associated with surgery.
The clinical variables are listed in Table 1. The mean
age was 66.6 ± 12 years (min. 22 years/max. 89 years).
N = 85 patients were male (69%) and 92.7% in the
New York Heart Association functional class > II. In
order to determine the pre-operative aortic diameter,
we performed transthoracic echocardiography or
radiological diagnostics (computer tomography). The
mean pre-operative aortic diameter measured 4.2 ± 0.6
cm (range 2.8-5.7 cm). None of the patients presented
with Marfan syndrome or other genetic disorders for
which aortoplasty would be contraindicated. In all patients,
the aortic dilatation was limited to the ascending aorta
without involvement of the aortic root or aortic arch. TheTable 1 Preoperative parameters
Items Number or mean ± SD Percent or range
Age (years) 66 ± 12 22-89
Male N = 85 69%
Body weight (kg) 76 ± 15 45 – 114
Body height (cm) 171 ± 8.5 152 – 189
Aortic valve disease N = 78 63%
Bicuspid N = 39 44%
Coronary heart disease N = 16 13%
Re-Operation N = 4 3%
Elective N = 99 80%
Euroscore I 4.2 ± 2.1 1-15
Aortic ascendens
diameter (cm)
4.2 ± 0.6 2.8-5.7primary indication for surgery was aortic valve disease in
n = 73 (63%) of patients. In n = 16 (13%) of patients, an
aortocoronary bypass presented an indication for sternot-
omy. In addition to the dilatation of the ascending aorta,
primary cardiac surgery was indicated in all patients.
Reduction ascending aortoplasty was performed as
concomitant secondary surgery (Table 2).
Surgical technique
After complete longitudinal sternotomy in 63% of all
patients (27% underwent partial upper sternotomy), a
cardiopulmonary bypass was established under moderate
hypothermia (34°C). The reduction ascending aorto-
plasty consisted of the direct resection of an oval section
of the anterior wall of the ascending aorta. The expected
reduction was calculated with the Roman formula [11]
(circumference = 2πr (r = radius, π = 3.14). The aortot-
omy was then adjusted in two layers with 4/0 Prolene™
(Ethicon Inc. USA) suture material. The aortoplasty was
not additionally supported mechanically with prosthetic
material. All associated indications for cardiac surgery
were performed before the aortoplasty.
The patient follow-up data was initially collected by
means of postal letters, telephone interviews and subse-
quent transthoracic echocardiography. If a CT of the
chest had already been performed after hospitalization,
echocardiography was not carried out and the data from
the radiology test was used. The cumulative follow-up
period consisted of 565 patient years and was concluded
at 95% (N = 119/124) for the endpoint “survival”. An
echocardiography was performed in 65 patients. The
median follow-up period was 55 months and the mean
follow-up time was 57 ± 34 months.
Statistical analysis
Continuous variables were specified as mean value ±
standard deviations. Nominal variables were described as
numbers and percentages. Life tables were calculated
with the Kaplan-Meier method. Significant predictors
for a re-dilatation were first examined in a univariate
analysis followed by a gradual logistic regression analysis.Table 2 Perioperative procedures




Aortic valve reconstruction 15 12%





Distal bypass anastomoses 2,1 ± 1,2 1-6
Aortic wall resection (cm) 1.6 ± 0.9 0.6-5
Figure 1 Kaplan Meier Curve for Survival after aortoplasty procedure.
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analysis were entered into the regression model. A p-value
of less than 0.05 was considered to be statistically signifi-
cant. Statistical analyses were carried out with the SPSS
21.0 software package (SPSS Inc., IBM, NY).Results
Postoperative and perioperative mortality and morbidity
Already during the primary hospitalization, 5 patients
(4%) died within the first 30 days after the procedure. The
cause of death was low cardiac output syndrome (n = 3) as
well as multiple organ failure (n = 2). Acute antegrade dis-
section was not reported.Table 3 Follow up
Items Number or mean ± SD Percent or range
Age (years) 72 ± 11 37 – 97
Lost to follow up 5/124 4%Long-term survival
20 cases of late death occurred within the entire follow-up
period. The patients’ mean age of death was 72 ± 11 years.
The exact causes of death could not be established.
No autopsies were performed (Figure 1).Mortality rate 20 21%
Atrial fibrillation 27 27%
Aortic ascendens
diameter (cm)
3.6 ± 0.6 2.3-4.9
Re-operation Aortic site 4 4%
Warfarin therapy 31 31%
NYHA III-IV 8 8%Complications
4 of 124 patients experienced increased secondary haem-
orrhaging after surgery which could not be managed
despite conservative medicinal therapy. Re-thoracotomy
provided evidence of the source of the haemorrhage at
the aortoplasty suture line. The bleeding was stopped in
all cases with surgical intervention (Table 3).Redilatation and repeat surgery
With the technique applied for the reduction ascending
aortoplasty, the aortic diameter (3.6 ± 0.6 cm range
2.3-4.9 cm) in the area of the ascending aorta was
significantly reduced by 0.6 cm (P = 0.001) (Figure 2).
Progression of the aortic dilatation occurred in 4 patients
(Figure 3). With a baseline diameter of 3.3 ± 0.5 cm, the
cross-section increased by an average of 0.9 cm in these
patients (4.2 ± 0.7cm). In the remaining patients (94%) the
diameter was maintained with the reduction aortoplasty
technique (n = 30) or decreased (n = 29). Repeat surgery
with the indication of aortic revision were not reported
during the follow-up period.
Predictors for redilatation: Only the preoperative diam-
eter was identified as a significant predictor for redilatation.
Figure 2 Boxplot of pre- and postoperative mean diameter of aortic roots after aortoplasty.
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baseline diameter of <40 mm where redilatation was not
observed. Other pre- and intra-operative variables (e.g. sur-
geon) could not be evaluated as a predisposing factor for
redilatation.
Discussion
The reduction ascending aortoplasty is a minimally inva-
sive therapy option for dilatations of the ascending aortaFigure 3 Changes of pre- and postoperative aortic diameters.and a viable alternative to radical aortic replacement. It
is generally used for patients with borderline aortic dila-
tation or increased surgical risks [9]. Reduction aorto-
plasty can effectively decrease the aortic diameter or
prevent further dilatation, shorten the aortic clamping
time, and decrease the rate of mortality and morbidity
[12,13]. Postoperative complications were mainly caused
by the primary indication for surgery (aortic valve replace-
ment or CABG). The good results of the perioperative
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cending aorta. Replacement of the ascending aorta has a
higher perioperative mortality and morbidity [4,5,14-16],
but is justified by the number of different indications
for surgery and patient characteristics [13]. Aortoplasty
is contraindicated in patients requiring aortic replace-
ment (type A aortic dissection, Marfan syndrome, cys-
tic medial necrosis). Reduction ascending aortoplasty
is generally performed in older patients with a high
perioperative risk and in combination with another
concomitant heart surgery. The greatest concerns with
regard to aortoplasty as surgical treatment pertain to
the rate of re-dilatations and mortality. During our
follow-up study, 20 patients died. The causes are not
known, but in view of concomitant combined cardiac
procedures, connections to the underlying cardiac dis-
ease can be derived. The results are comparable with
those of other studies [2,8,9]. Bauer et al. [13] reports a
survival rate of 94% after 5 years and regards the
aortoplasty-related mortality as very low. He believes
that the reduction ascending aortoplasty has no effect
on medium-term or long-term survival.
Literature research on the occurrence of re-dilatation
after RAA shows contradictory results with rates of 0%
to 25% [12,13,17]. The lack of external support (wrap-
ping) is made responsible for the differences, but a direct
comparison between the studies is difficult due to the in-
homogeneous groups. Arsan et al. [12] reports 35% of
patients with a combined aortic valve replacement as
compared to Bauer et al, where 89% of patients received
aortic valve replacement with RAA. In our study, the
most relevant valvular heart disease was aortic valve re-
placement associated with relevant stenosis (63%) while
Bauer et al. [13] reported a percentage of 47%. Muller
et al. [18] also reports that all re-dilatations occurred in
patients with Marfan syndrome, while other authors
classified Marfan syndrome as an absolute contraindica-
tion for RAA [19-21]. We determined an absence of re-
dilatation of 94% over a period of 10 years. Four patients
had re-dilatation of the ascending aorta which did not
require surgery. This result is similar to that of Bauer
[13], Kamada [22] and Polvani [17]. There is a general
consensus that RAA should not be performed on pa-
tients with an aortic aneurysm of more than 60 mm [2].
This is why this patient population is not represented in
our population. Univariate and multivariate analyses
confirm that the pre-operative diameter is the most im-
portant factor for RAA. However, these results mainly
applied to a diameter of more than 55 mm [2]. However,
our analysis also shows that at the other end of the ex-
treme values, reduction ascending aortoplasty may fail,
namely in those patients for whom dilatation of the
aorta constitutes a borderline indication for surgery or a
normal physiological width.Limitations
The validity of this study is very limited. The following
aspects should be critically noted: The study was only
conducted in a selected subgroup of patients (maximum
diameter of 57 mm). There are no control groups where
either no surgery was performed on the aorta or aortic
replacement was carried out. Histology results on the
morphology of the aortic wall were not collected. A 95%
follow-up rate with regard to the primary endpoint
“death” is acceptable, but only 65% of patients could be
motivated to undergo a follow-up echocardiography (re-
dilatation as secondary endpoint).
Conclusion
For our patient population, reduction ascending aorto-
plasty is a safe and effective treatment option in patients
with dilated ascending aorta (<50 mm) or significant
contraindications for aortic replacement.
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